Side by side
Compare
Search a ticker or company to build a side-by-side comparison of sourced identity, market snapshot and verified financials. Share prices stay live on this page; deeper reporting stays on each Company File.
Build the set
Choose 2–4 instruments
- TAK
Quick examples
One instrument selected. Add another to compare.
| Field | TAK |
|---|---|
| Instrument | |
| Name | Takeda Pharmaceutical Company Limited |
| Kind | Stock |
| Exchange | NYSE |
| Category | Operating company |
| What it tracks / does | Takeda is a global biopharmaceutical company that discovers, develops, and commercializes medicines, including treatments in oncology, rare genetics and hematology, neuroscience, and gastroenterology. |
| Company File | Available |
| Latest verified financials | |
| Reporting period | FDA Mimrylo (rusfertide) approval August 28, 2026; Takeda same-day release |
| Revenue | Not available |
| Net income | Not available |
| Diluted EPS | Not available |
| Sources | |
| Primary source | Takeda Pharmaceutical Company Limited Form 20-F business description |
| Verified financials | Open IR release |
| Latest quote | Latest quote |
Broad-market ETFs currently covered: VOO, QQQ, DIA. An ETF share price is not the index it tracks. Valuation, profitability and return rows stay off this table.